Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer

General Hospital Psychiatry

Volumn 35, Issue 4, 2013, Pages 376-381

  Reece, Julia C ^a   Chan, Ya Fen ^a   Herbert, Julia ^a   Gralow, Julie ^a,b,c   Fann, Jesse R ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Anxiety; Breast cancer; Depression; Health services; Treatment

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESCITALOPRAM; FLUOROURACIL; METHOTREXATE; PACLITAXEL; SERTRALINE;

ADULT; ANOREXIA; ANXIETY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DSM-IV; EDUCATIONAL STATUS; FATIGUE; FEMALE; GENERALIZED ANXIETY DISORDER 7 SCALE; HEALTH CARE UTILIZATION; HUMAN; LONGITUDINAL STUDY; MASTECTOMY; MENTAL HEALTH SERVICE; NAUSEA; PAIN; PARESTHESIA; PARTIAL MASTECTOMY; PATIENT COUNSELING; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT PREFERENCE; PHYSICAL DISEASE; PREMENOPAUSE; PREVALENCE; PROSPECTIVE STUDY; PSYCHOMETRY; QUESTIONNAIRE; RISK FACTOR; SKIN TINGLING; SLEEP DISORDER; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS; ANXIETY DISORDERS; BREAST NEOPLASMS; COHORT STUDIES; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; MENTAL HEALTH SERVICES; MIDDLE AGED; PATIENT PREFERENCE; PROSPECTIVE STUDIES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 84879464686     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.03.017     Document Type: Article

References (46)

1. Fann J.R., Thomas-Rich A.M., Katon W.J., Cowley D., Pepping M., McGregor B.A., Gralow J. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008, 30(2):112-126.
2. Reich M., Lesur A., Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008, 110(1):9-17.
3. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004, 32:57-71.
4. Zabora J., BrintzenhofeSzoc K., Curbow B., Hooker C., Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology 2001, 10(1):19-28.
5. Burgess C., Cornelius V., Love S., Graham J., Richards M., Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005, 330(7493):702.
6. Rowland J. Anxiety and the blues after breast cancer: how common are they?. CNS Spectr 1999, 4:40-54.
7. Hack T.F., Pickles T., Ruether J.D., Weir L., Bultz B.D., Mackey J., et al. Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role. Psychooncology 2010, 19(6):606-616.
8. So W.K., Marsh G., Ling W.M., Leung F.Y., Lo J.C., Yeung M., et al. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 2010, 14(1):17-22.
9. Dodd M.J., Cho M.H., Cooper B.A., Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 2010, 14(2):101-110.
10. Tchen N., Juffs H.G., Downie F.P., Yi Q.L., Hu H., Chemerynsky I., et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003, 21(22):4175-4183.
11. Longman A.J., Braden C.J., Mishel M.H. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncol Nurs Forum 1999, 26(5):909-915.
12. Hermelink K., Kuchenhoff H., Untch M., Bauerfeind I., Lux M.P., Buhner M., et al. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 2010, 19(12):1321-1328.
13. de Jong N., Candel M.J., Schouten H.C., Abu-Saad H.H., Courtens A.M. Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 2005, 16(3):372-382.
14. Ayres A., Hoon P.W., Franzoni J.B., Matheny K.B., Cotanch P.H., Takayanagi S. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 1994, 38(5):393-402.
15. Rao M.R., Raghuram N., Nagendra H.R., Gopinath K.S., Srinath B.S., Diwakar R.B., et al. Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med 2009, 17(1):1-8.
16. Prigozin A., Uziely B., Musgrave C.F. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer. Oncol Nurs Forum 2010, 37(6):E411-E418.
17. Vahdaninia M., Omidvari S., Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 2010, 45(3):355-361.
18. Navari R.M., Brenner M.C., Wilson M.N. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2008, 112(1):197-201.
19. Hewitt M., Herdman R., Holland D. Meeting psychosocial needs of women with breast cancer 2004, The National Academies Press, Washington, DC.
20. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
21. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. 4th ed., Text Revision.
22. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 1999, 282(18):1737-1744.
23. Arroll B., Goodyear-Smith F., Crengle S., Gunn J., Kerse N., Fishman T., et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010, 8(4):348-353.
24. Thekkumpurath P., Walker J., Butcher I., Hodges L., Kleiboer A., O'Connor M., et al. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer 2011, 117(1):218-227.
25. Fann J.R., Bombardier C.H., Dikmen S., Esselman P., Warms C.A., Pelzer E., et al. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. J Head Trauma Rehabil 2005, 20(6):501-511.
26. Lowe B., Decker O., Muller S., Brahler E., Schellberg D., Herzog W., et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008, 46(3):266-274.
27. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166(10):1092-1097.
28. Cleeland C.S., Mendoza T.R., Wang X.S., Chou C., Harle M.T., Morrissey M., et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000, 89(7):1634-1646.
29. Sirey J.A., Meyers B.S., Teresi J.A., Bruce M.L., Ramirez M., Raue P.J., et al. The Cornell Service Index as a measure of health service use. Psychiatr Serv 2005, 56(12):1564-1569.
30. Rissling M.B., Liu L., Natarajan L., He F., Ancoli-Israel S. Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy. Support Care Cancer 2011, 19(8):1107-1115.
31. Browall M.M., Ahlberg K.M., Persson L.O., Karlsson P.O., Danielson E.B. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol 2008, 47(2):207-215.
32. Chen X., Zheng Y., Zheng W., Gu K., Chen Z., Lu W., et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol 2009, 48(8):1128-1136.
33. Golden-Kreutz D.M., Andersen B.L. Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psychooncology 2004, 13(3):211-220.
34. Mehnert A., Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 2007, 16(3):181-188.
35. Gum A.M., Arean P.A., Hunkeler E., Tang L., Katon W., Hitchcock P., et al. Depression treatment preferences in older primary care patients. Gerontologist 2006, 46(1):14-22.
36. van Schaik D.J., Klijn A.F., van Hout H.P., van Marwijk H.W., Beekman A.T., de Haan M., et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004, 26(3):184-189.
37. Young A.S., Klap R., Sherbourne C.D., Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58(1):55-61.
38. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008, 27:32.
39. Onitilo A.A., Nietert P.J., Egede L.E. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry 2006, 28(5):396-402.
40. Hegel M.T., Moore C.P., Collins E.D., Kearing S., Gillock K.L., Riggs R.L., et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006, 107(12):2924-2931.
41. Drell T.L., Joseph J., Lang K., Niggemann B., Zaenker K.S., Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003, 80(1):63-70.
42. Su F., Ouyang N., Zhu P., Ouyang N., Jia W., Gong C., et al. Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. Biochem Biophys Res Commun 2005, 329(3):888-897.
43. Fann J.R., Berry D.L., Wolpin S., Austin-Seymour M., Bush N., Halpenny B., et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology 2009, 18(1):14-22.
44. Kornblith A.B., Lan L., Archer L., Partridge A., Kimmick G., Hudis C., et al. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol 2011, 29(8):1022-1028.
45. Eversley R., Estrin D., Dibble S., Wardlaw L., Pedrosa M., Favila-Penney W. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 2005, 32(2):250-256.
46. Christie K.M., Meyerowitz B.E., Maly R.C. Depression and sexual adjustment following breast cancer in low-income Hispanic and non-Hispanic White women. Psychooncology 2010, 19(10):1069-1077. 10.1002/pon.1661.